Anthropic 与澳大利亚政府签署备忘录，承诺与澳 AI 安全研究所共享前沿模型风险研究及经济指数数据，并探索在当地投资数据中心。公司宣布向澳大利亚国立大学等四家机构提供 300 万澳元 Claude API 积分，支持罕见疾病基因分析与计算机教育；同时推出深科技初创企业计划，提供最高 5 万美元 API 积分用于药物发现等领域。Anthropic 还将开设悉尼办公室作为亚太扩张起点。
原文 · 未翻译
Australian government and Anthropic sign MOU for AI safety and research
Today, Anthropic signed a Memorandum of Understanding with the Australian government to cooperate on AI safety research and support the goals of Australia’s National AI Plan. Our CEO, Dario Amodei, met with Prime Minister Anthony Albanese to formalize the agreement during a visit to Canberra, Australia. We also announced AUD$3 million in partnerships with leading Australian research institutions to use Claude to improve disease diagnosis and treatment and support computer science education and research.
Central to the MOU is a commitment to work with Australia’s AI Safety Institute. We will share our findings on emerging model capabilities and risks, participate in joint safety and security evaluations, and collaborate on research with Australian academic institutions. This mirrors the arrangements we have with safety institutes in the US, UK, and Japan, where early access and technical information sharing has helped governments build an independent view of where frontier AI is heading, and AI developers increase the safety of their models. Under the MOU, we will share Anthropic Economic Index data with the Australian government to help track how AI is being adopted across the economy, its economic impacts, and the implications for workers. We’ll initially focus on sectors critical to Australia’s economy, including natural resources, agriculture, healthcare, and financial services. As part of this, we plan to develop ways to advance AI education and training within the workforce. Our recent Economic Index data shows that Australians already use Claude for a broader range of tasks than most countries—the most diverse among English-speaking nations—and work collaboratively with AI using sophisticated prompts to accomplish high-skill tasks ranging from management and sales and business operations, to use in the life sciences and in everyday life. Finally, in line with Australia’s National AI plan, we are exploring investments in data center infrastructure and energy throughout the country, aligned with the government’s recently announced data center expectations.
“Australia’s investment in AI safety makes it a natural partner for responsible AI development. This MOU gives our collaboration a formal foundation,” said Anthropic CEO Dario Amodei. “ I'm particularly excited by the work Australian research institutions will be doing with Claude to advance disease diagnosis and treatment."
Anthropic 与澳大利亚政府签署备忘录，承诺与澳 AI 安全研究所共享前沿模型风险研究及经济指数数据，并探索在当地投资数据中心。公司宣布向澳大利亚国立大学等四家机构提供 300 万澳元 Claude API 积分，支持罕见疾病基因分析与计算机教育；同时推出深科技初创企业计划，提供最高 5 万美元 API 积分用于药物发现等领域。Anthropic 还将开设悉尼办公室作为亚太扩张起点。
原文 · 保持原样，未翻译
Australian government and Anthropic sign MOU for AI safety and research
Today, Anthropic signed a Memorandum of Understanding with the Australian government to cooperate on AI safety research and support the goals of Australia’s National AI Plan. Our CEO, Dario Amodei, met with Prime Minister Anthony Albanese to formalize the agreement during a visit to Canberra, Australia. We also announced AUD$3 million in partnerships with leading Australian research institutions to use Claude to improve disease diagnosis and treatment and support computer science education and research.
Central to the MOU is a commitment to work with Australia’s AI Safety Institute. We will share our findings on emerging model capabilities and risks, participate in joint safety and security evaluations, and collaborate on research with Australian academic institutions. This mirrors the arrangements we have with safety institutes in the US, UK, and Japan, where early access and technical information sharing has helped governments build an independent view of where frontier AI is heading, and AI developers increase the safety of their models. Under the MOU, we will share Anthropic Economic Index data with the Australian government to help track how AI is being adopted across the economy, its economic impacts, and the implications for workers. We’ll initially focus on sectors critical to Australia’s economy, including natural resources, agriculture, healthcare, and financial services. As part of this, we plan to develop ways to advance AI education and training within the workforce. Our recent Economic Index data shows that Australians already use Claude for a broader range of tasks than most countries—the most diverse among English-speaking nations—and work collaboratively with AI using sophisticated prompts to accomplish high-skill tasks ranging from management and sales and business operations, to use in the life sciences and in everyday life. Finally, in line with Australia’s National AI plan, we are exploring investments in data center infrastructure and energy throughout the country, aligned with the government’s recently announced data center expectations.
Extending AI for Science to Australia’s research and innovation sector
At Anthropic, we believe that AI has the potential to significantly accelerate scientific progress. To this end, we are extending our AI for Science program to Australia, starting with an investment of AUD$3 million in Claude API credits to four institutions applying AI to some of humanity’s most pressing challenges. New partnerships with the Australian National University, Murdoch Children’s Research Institute, the Garvan Institute of Medical Research, and Curtin University will support areas like clinical genomics and precision medicine, pediatric medical research, and computing education.
A multidisciplinary team from the ANU John Curtin School of Medical Research is using Claude to analyze genetic sequencing data to help tackle rare diseases. The ANU School of Computing is also embedding Claude into new courses to train the next generation of Australian developers and scientists.
The Garvan Institute of Medical Research will use Claude to accelerate genomic discovery in two major research projects. The first, in partnership with UNSW, will build systems that translate human genetic variation into insights about how disease operates in specific cell types, with the goal of identifying new treatments. The second, with the Centre for Population Genomics, a joint initiative between Garvan and Murdoch Children’s Research Institute, will automate the complex genetic analysis that is currently the main bottleneck in diagnosing children with rare genetic conditions. Separately, Murdoch Children’s Research Institute will also apply Claude to its stem cell medicine program to improve identification of therapeutic targets for childhood heart disease.
Finally, the Curtin Institute for Data Science, Australia’s largest university-based data science research institute, will use Claude to scale their collaboration with academics, and in research projects across health sciences, the humanities, business, law, science, and engineering.
On Monday, we also announced that we are launching our first deep tech startup API credit program for VC-backed startups working on drug discovery, materials science, climate modeling, and medical diagnostics—areas where AI can have a profound impact. Eligible companies will receive up to USD$50,000 (about AUD$72,000) in API credits to build with Claude, along with resources and community support, as we build our local team.
These investments reflect the advanced work Australian researchers and startups are already doing with Claude, and directly contribute to supporting the goals outlined in Australia’s National AI Plan.
The visit to Australia marks the beginning of long-term collaboration and investment into the Asia-Pacific region. We’ll share more about our local team and leadership in the coming weeks as we prepare to open our Sydney office. You can read the details of the Australian government’s MOU with Anthropic here.
“Australia’s investment in AI safety makes it a natural partner for responsible AI development. This MOU gives our collaboration a formal foundation,” said Anthropic CEO Dario Amodei. “ I'm particularly excited by the work Australian research institutions will be doing with Claude to advance disease diagnosis and treatment."
Extending AI for Science to Australia’s research and innovation sector
At Anthropic, we believe that AI has the potential to significantly accelerate scientific progress. To this end, we are extending our AI for Science program to Australia, starting with an investment of AUD$3 million in Claude API credits to four institutions applying AI to some of humanity’s most pressing challenges. New partnerships with the Australian National University, Murdoch Children’s Research Institute, the Garvan Institute of Medical Research, and Curtin University will support areas like clinical genomics and precision medicine, pediatric medical research, and computing education.
A multidisciplinary team from the ANU John Curtin School of Medical Research is using Claude to analyze genetic sequencing data to help tackle rare diseases. The ANU School of Computing is also embedding Claude into new courses to train the next generation of Australian developers and scientists.
The Garvan Institute of Medical Research will use Claude to accelerate genomic discovery in two major research projects. The first, in partnership with UNSW, will build systems that translate human genetic variation into insights about how disease operates in specific cell types, with the goal of identifying new treatments. The second, with the Centre for Population Genomics, a joint initiative between Garvan and Murdoch Children’s Research Institute, will automate the complex genetic analysis that is currently the main bottleneck in diagnosing children with rare genetic conditions. Separately, Murdoch Children’s Research Institute will also apply Claude to its stem cell medicine program to improve identification of therapeutic targets for childhood heart disease.
Finally, the Curtin Institute for Data Science, Australia’s largest university-based data science research institute, will use Claude to scale their collaboration with academics, and in research projects across health sciences, the humanities, business, law, science, and engineering.
On Monday, we also announced that we are launching our first deep tech startup API credit program for VC-backed startups working on drug discovery, materials science, climate modeling, and medical diagnostics—areas where AI can have a profound impact. Eligible companies will receive up to USD$50,000 (about AUD$72,000) in API credits to build with Claude, along with resources and community support, as we build our local team.
These investments reflect the advanced work Australian researchers and startups are already doing with Claude, and directly contribute to supporting the goals outlined in Australia’s National AI Plan.
The visit to Australia marks the beginning of long-term collaboration and investment into the Asia-Pacific region. We’ll share more about our local team and leadership in the coming weeks as we prepare to open our Sydney office. You can read the details of the Australian government’s MOU with Anthropic here.